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on Cell Surfaces
of annexin V to the cell surface membrane and/or stabili-
zation of the entire molecular assembly to promote anti-
coagulation.
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Boston University School of Medicine Though annexins are found primarily within cells and
Boston, Massachusetts 02118 lack signal sequences, some also occur in extracellular
‡Department of Molecular and Cellular Physiology pools. Rand proposes the term annexinopathy in refer-
College of Medicine ence to blood disorders associated with extracellular
University of Cincinnati annexins [4]. Annexin II promotes fibrinolysis and serves
Cincinnati, Ohio 45220 as an endothelial cell surface receptor for plasminogen
and tissue plasminogen activator [5]. Abnormally high
levels of annexin II lead to excessive fibrinolysis in a
bleeding disorder associated with acute myelocytic leu-Summary
kemia [6]. Deficiency of annexin V, an abundant antico-
agulant protein particularly rich in placental tissue, hasBackground: Annexin V, an abundant anticoagulant
been identified as a causative factor in loss of pregnancyprotein, has been proposed to exert its effects by self-
associated with antiphospholipid syndrome (APS) [7].assembling into highly ordered arrays on phospholipid
A functional mechanism has been proposed in whichmembranes to form a protective anti-thrombotic shield
annexin V coats placental endothelial cells to serve asat the cell surface. The protein exhibits very high-affinity
a protective anti-thrombotic shield [8]. In APS, the loss ofcalcium-dependent interactions with acidic phospho-
this shield through attack from anti-annexin V antibodieslipid membranes, as well as specific binding to glycos-
removes this protection and allows excessive placentalaminoglycans (GAGs) such as heparin and heparan sul-
thrombosis to occur [9]. Shield formation is likely tofate, a major component of cell surface proteoglycans.
be achieved as a result of extensive self-assembly ofAt present, there is no structural information to elucidate
annexin V into highly ordered arrays on acidic phospho-this interaction or the role it may play in annexin V func-
lipid membrane surfaces [10].tion at the cell surface.
Calcium-dependent glycosaminoglycan (GAG) bind-
ing to annexins has been reported and characterized in
Results: We report the 1.9 A˚ crystal structure of annexin several in vitro studies [11–15]. Cell surface proteogly-
V in complex with heparin-derived tetrasaccharides. cans prominently displayed on cell surfaces contain
This structure represents the first of a heparin oligosac- GAGs such as heparan sulfate and chondroitin sulfate.
charide binding to a protein where calcium ions are These polysaccharides are linear polymers with re-
essential for the interaction. Two distinct GAG binding peating sequences that may contain hundreds of sugar
sites are situated on opposite protein surfaces. Basic residues. Dozens of proteins, many of which are involved
residues at each site were identified from the structure in blood coagulation, exhibit functionally relevant inter-
and site-directed mutants were prepared. The heparin actions with GAGs, especially heparin or heparan sulfate
binding properties of these mutants were measured by [16]. It has been proposed that extracellular annexins
surface plasmon resonance. The results confirm the can serve as GAG-recognition elements in vivo [13]. The
roles of these mutated residues in heparin binding, and molecular details of calcium-dependent GAG binding
the kinetic and thermodynamic data define the function- to annexins have not been elucidated, particularly with
ally distinct character of each distal binding surface. respect to the relationship between GAG and phospho-
lipid membrane binding, and the functional implications
are not yet understood. In the present studies, crystallo-Conclusion: The annexin V molecule, as it self-assem-
graphic data were sought to shed light on the complexesbles into an organized array on the membrane surface,
formed between annexin V and highly purified heparin-can bind the heparan sulfate components of cell surface
derived tetrasaccharides (HTS) of the sequence DU-proteoglycans. A novel model is presented in which pro-
Ap2S (1!4)-a-D-GlcNpS6S (1!4)-a-L-IdoAp2S (1!4)-teoglycan heparan sulfate could assist in the localization
a-D-GlcNpS6S (designated residues A, B, C, and D,
respectively) (Figure 1).
§ To whom correspondence should be addressed (e-mail: seaton@
med-xtal.bu.edu).
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Figure 1. Structural Representation of HTS
DUAp2S(1!4)-a-D-GlcNpS6S(1!4)-a-L-
IdoAp2S(1!4)-a-D-GlcNpS6S (residues
A-B-C-D shown left to right).
Results and Discussion oxygen atoms form hydrogen bonds to backbone nitro-
gen atoms in the IAB calcium binding loop. Additional
hydrogen bonds are formed with water molecules thatHeparin Tetrasaccharide Binding Sites
on Annexin V coordinate the bound calcium ions in both loops, and
with a serine side chain in the IDE loop. The calciumIn the 1.9 A˚ crystal structure of the HTS-annexin V com-
plex, two HTS molecules lie along distal surfaces of the coordination is the same as in the absence of HTS. The
data suggest that because the loops are conformation-protein (Figure 2). The annexin V monomer consists of
four homologous domains arranged in pairs, forming an ally sensitive to the presence of bound calcium ions, the
calcium-dependence of the annexin-heparin interactionapproximately circular, slightly curved disk. The convex
face binds the membrane surface through calcium bind- arises primarily through inducing the requisite confor-
mation for heparin binding. Another important determi-ing loops [17] and other determinants [18] that foster
very high-affinity (Kd , nM) interactions with the acidic nant of the HTS-1 binding site is a basic cluster that
includes Arg-23, Lys-27, Arg-61, and Arg-149 from thephospholipid membrane [19], while the concave face is
oriented toward the aqueous environment. In the com- adjacent monomer (Figure 3). Studies of annexin V bind-
ing to liposomes have shown that this basic clusterplex, one HTS molecule is found at the convex surface,
in close proximity to calcium binding loops in domain I participates in phospholipid membrane binding (B.
Seaton, personal communication).(the HTS-1 site). The second HTS molecule binds at the
concave surface of the protein (the HTS-2 site), which Unlike the HTS-1 site, which is formed exclusively
within domain I, the HTS-2 site spans the two half-mole-is not associated with calcium binding. At both sites,
contacts between the protein and HTS molecules are cule lobes of the annexin molecule by incorporating
determinants from domains I, II, and III (Figure 4). Tet-principally through main-chain amide nitrogen atoms
and arginine side chains (Tables 1 and 2), stabilized by rasaccharide residues A and B (DUAp2S 901 and
GlcNpS6S 902, respectively) interact solely with thean elaborate network of water molecules. No changes
in annexin V conformation, other than in side-chain posi- charged N terminus and main-chain amide nitrogens of
the first two N-terminal residues. Tetrasaccharide resi-tions, are observed when the native and HTS-com-
plexed annexin V structures are compared, consistent dues C and D (IdoAp2S 903 and GlcNpS6S 904, respec-
tively) form numerous electrostatic interactions with IIICwith circular dichroic spectral measurements [12].
The HTS-1 site is formed by the first and second cal- helix residues Arg-205 and Arg-206, as well as hydrogen
bonds with backbone and side-chain residues from thecium binding loops, termed IAB and IDE, respectively,
with reference to the numbered annexin domain and extended loop connecting domains II and III. Conse-
quently, HTS residues A and B bind exclusively to deter-lettered helices flanking each loop [20]. Despite the strict
calcium-dependence of heparin binding to annexin V minants from one lobe, and residues C and D from the
other. The low average b-factors of saccharide residues[13, 14] and the importance of sulfate groups to the
association [13], HTS sulfate atoms do not interact di- C and D (23.2 A˚2 and 19.9 A˚2, respectively, compared
with an average of 47.8 A˚2 for the HTS molecule) suggestrectly with annexin-bound calcium ions. Instead, sulfate
Figure 2. HTS Molecules Bind on Opposite Surfaces of Annexin V, Shown in Stereo View
Ribbon diagram of protein (cyan), HTS atoms colored as follows: carbon (gray), nitrogen (blue), oxygen (red), sulfur (green). Calcium ions,
depicted as yellow spheres, appear on the membrane binding convex surface.
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Table 2. Contacts Between HTS2 and the Heparin-binding SiteTable 1. Contacts Between HTS1 and the Heparin-binding Site
on the Membrane-binding Surface of Annexin V on the Exposed Surface of Annexin V
F4 Residue Atom Protein Atom Distance (in A˚) F4 Residue Atom Protein Atom Distance (in A˚)
801 DUap2S (UAP) 901 DUap2S (UAP)
O5 (ring) Ala2N 2.76O22 (sulfate) Leu29N 2.92
O24 (sulfate) Leu29N 2.93 O6 (carboxylate) Ala2N 3.02
902 GlcNS6S (SGN)802 GlcNS6S (SGN)
O62 (sulfate) Gly28N 2.68 O62 (sulfate) Ala2N 2.77
O63 (sulfate) Leu3N 3.06O63 (sulfate) Arg23NH1 2.56
O64 (sulfate) Arg23NH2 2.73 903 IdoAp2S (IDU)
O22 (sulfate) Arg206NH1 2.65O5 (ring) Arg61NH2 2.91
O6 (ring) Arg61NH2 3.20 O22 (sulfate) Arg206NH2 3.42
O23 (sulfate) Arg205NH1 3.53803 IdoAp2S (IDU) none none
804 GlcNS6S (SGN) O24 (sulfate) Arg205NH1 2.64
904 GlcNS6S (SGN)N (sulfate) Ser69OH 2.82
O3 (ring) Ser69OH 2.73 O63 (sulfate) Arg206NH2 3.37
O64 (sulfate) Arg206NH2 2.54
O1 (ring) Thr163N 3.20
O1 (ring) Thr163O 2.67
that the binding pocket containing arginines 205 and 206
is the more important heparin binding HTS-2 subsite.
Heparin Tetrasaccharide Conformation consistent with the solution conformation of this residue
[23]. The glucosamine residues (GlcNpS6S, residues BThe helical conformation of both heparin tetrasaccha-
rides is consistent with the structures observed by nu- and D) are in the predominant 4C1 conformation, as is
expected for these residues [21, 23].clear magnetic resonance for the heparin-derived do-
decasaccharide [21]. The respective monosaccharide The conformational flexibility of the IdoAp2S residue
has been proposed to play a role in interactions betweenresidues in HTS-1 and HTS-2 are almost identical in their
conformations. Heparinase I depolymerization produces, heparin and a variety of proteins [24]. The two major
conformations of the internal IdoAp2S residue, the 1C4at the non-reducing end, a terminal uronate residue with
an unsaturated 4,5-carbon bond (DUAp2S, residue A). chair and the 2S0 skew boat, are energetically similar
[25]. In the crystal structure of FGF-2 bound to a heparinBased on the conformation about this double bond,
these residues can exist in either the 2H1 or 1H2 forms tetrasaccharide [26], this residue makes contact with
the protein and resides in a 1C4 chair. In solution NMR[22]. In both tetrasaccharides in the HTS-annexin com-
plex, the terminal uronate is represented by the 1H2 form, conformational studies, the unbound IdoAp2S residue
Figure 3. Two Views of the HTS-1 Site on the
Convex Surface of Annexin V, Shown in
Stereo View
Calcium ions are depicted as large yellow
spheres, and water molecules, as small red
spheres. Atomic interactions (hydrogen bonds,
metal ion coordination) are indicated as dot-
ted green lines. (a) top: HTS-1 saccharide in-
teractions with IAB and IDE calcium binding
loops of annexin V. (b) Saccharide residues
A and B interact with the IAB loop backbone
and with arginine side chains from the proxi-
mal basic cluster.
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Figure 4. Simulated-Annealing Omit Electron
Density Map, Contoured at 1s, Omitting the
HTS-2 Atoms
Saccharide residues designated A, B, C, and D.
prefers a 2S0 conformation [23]. In the present annexin helix were probed using site-directed mutagenesis and
surface plasmon resonance (SPR) . Mutants of arginineV complex, the HTS-2 IdoAp2S residue interacts with
the protein in the 2S0 conformer, while the non-inter- residues were engineered at the HTS-1, HTS-2, and the
predicted site on the IVC helix: Arg-23!Glu (R23E),acting HTS-1 IdoAp2S residue resides in the 1C4 chair.
Arg-205!Ala (R205A), and Arg-287!Ala (R287A), re-
spectively. SPR measurements were performed toMutational Analysis of Heparin Binding Sites
quantitate interactions between immobilized full-lengthOther studies suggest the existence of heparin binding
heparin and wild-type or mutant annexin V.sites that are not observed in the annexin V crystal struc-
In the presence of 5 mM calcium, binding curves ofture. On the concave surface, a heparin binding motif,
wild-type annexin V show a fast association kineticwhich includes Arg-283, Lys-284, Arg-287 and Lys-288
phase and a very gradual dissociation phase (Figure 5).from the C helix in domain IV, has been identified [27]
The binding is of high-affinity, with a calculated Kd ofconsistent with the suggestion of Waisman and cowork-
20 nM (Table 3), similar to values reported previouslyers in their studies of annexin II [12]. Additional heparin
[14]. As compared with wild-type annexin V, the R23Ebinding sites are less likely to occur on the convex sur-
mutant exhibits a rapid association phase but a slightlyface, which has numerous calcium binding loops but
lower response (RU) and a very fast dissociation fromnone with the basic cluster characteristics of domain I.
the heparin support. Because rapid association occursThe heparin binding capabilities at the two observed
in the absence of Arg-23, this residue is not crucial forHTS binding sites and the predicted site on the IVC
the initial binding of heparin. However, the Kd of the R23E
mutant drops to 970 nM, a 50-fold decrease relative to
wild-type, indicating that Arg-23 contributes to heparin
binding affinity. Therefore, the convex surface HTS-1
site is not the recognition site for heparin binding to
annexin V but augments the affinity of the interaction.
In contrast, mutants from the sites on the concave
surface both undergo a dramatic decrease in heparin
binding affinity. The R287A mutant from the predicted
heparin binding site shows a very gradual association
phase and a gradual dissociation phase, a 4-fold reduc-
tion in the RU, and more than a 1000-fold increase in
Kd. These results support the hypothesis that heparin
binding is associated with the heparin binding motif in
the IVC helix [12]. The data also show that Arg-287 plays
a role in the initial heparin recognition process, as evi-
denced by the slow association phase, and that this
residue also contributes significantly to the binding af-
Figure 5. Comparison of the Sensograms of Annexin V (blue) and
finity. An even greater loss of affinity, more than 10-foldR23E (red), R287A (green), R205A (yellow) Mutants
over R287A, is observed in the increased Kd of R205A.A 1.5 mM protein sample was passed over a heparin surface. The
Arg-205 thus appears to be one of the residues responsi-rising portion of the curves (from z50 s) correspond to association
and the falling portions (from z230 s) correspond to dissociation. ble for the initial recognition and binding to heparin. No
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dues, to reach the heparin binding motif that includesTable 3. SPR-Derived Kinetic and Equilibrium Constants
for Binding of Annexin V and Mutants to Heparin Arg-287 on helix IVC. The GAG molecule would complete
its extended binding interaction by making contact withAnnexin V kon (M21 s21) koff (s21) Kd (M)
the HTS-1 site on the convex face (Figure 6A). Computer
Wild type 7.6 3 104 1.5 3 1023 20.0 3 1029 modeling shows that a heparin sequence containing 26
R23E 3.3 3 104 0.032 9.7 3 1027
saccharide residues would be of sufficient length toR287A§ 25.0 3.2 3 1024 1.3 3 1025
make this full contact. A similar wrap-around model hasR205A 36.0 4.1 3 1023 1.1 3 1024
been reported for the interaction of heparan sulfate with
§ The kon, koff and Kd for wild-type annexin V, R23E, and R205A were platelet factor IV [29].
calculated from the sensograms obtained at multiple concentrations
Heparan sulfate binding on the concave surface of(0.25–1.5 mM), while the values for R287A could only be accurately
annexin V would not be expected to interfere with thedetermined at 0.9 mM.
essential annexin-membrane association. However the
site on the convex surface would be affected by mem-
brane binding. In vitro solution studies show that heparin
binding to the heparin chip is observed in the absence binding cannot compete effectively with phospholipid
of calcium for either wild-type or mutant annexin V pro- membrane binding to annexin V [13], an association that
teins. is higher in affinity by orders of magnitude [19]. The
Although the mutations diminish heparin binding, the in vivo implications are that if heparan sulfate binding
tertiary structures of the three mutants appear to be preceded membrane adsorption, the GAG would be dis-
maintained. In annexin V, calcium-dependent mem- placed from the convex surface; if adsorption occurred
brane binding is very sensitive to structural perturbation first, only the concave surface binding sites would be
(B. Seaton, personal communication). This property was available (Figure 6B). Either way, the annexin molecule
assayed for each mutant using fluorescence resonance is capable of binding both membrane and proteoglycan
energy transfer (FRET). The adsorption of the R205A GAG chain concurrently. Though the annexin-heparin
and R287A mutants to liposomes is comparable to that interaction is calcium-dependent in vitro, this property
of wild-type; a similar phenotype has been reported for is less likely to carry much significance in vivo. In the
the equivalent mutant, R207A, in human annexin V [28]. extracellular environment, free calcium levels are suffi-
On the other hand, the R23E mutant exhibits markedly ciently high for annexin V to remain membrane-bound
reduced liposome binding in the FRET assay, consistent on acidic phospholipid surfaces of activated cells. How-
with the localization of Arg-23 at the membrane binding ever, as noted above, calcium ions conformationally sta-
surface. A low-resolution (3 A˚) crystal structure of the bilize the heparin binding surface that is utilized when
R23E mutant reveals no significant conformational dif- annexin V is not bound to phospholipids. Calcium bind-
ferences from wild-type annexin V (B. Seaton, personal ing thus contributes to the overall affinity of the annexin-
communication). Therefore the distinct heparin binding heparin interaction when annexin V is free in solution
capabilities of each mutant are associated with loss of rather than membrane-bound, i.e., when the cell surface
specific binding interactions with heparin rather than a has not been activated.
loss of tertiary structure caused by the mutation.
Model of In Vivo Annexin–Heparin Binding Comparison with Other Heparin Binding Proteins
In addition to the annexins, there is only one other familyFrom the present structural and kinetic data, we propose
a model in which recognition and binding of full-length of membrane binding proteins, apolipoprotein E (apoE),
with well-characterized heparin binding properties. Hep-heparin initially occurs on the concave annexin surface,
at the HTS-2 site incorporating Arg-205 and -206. In this aran sulfate proteoglycan on the cell membrane serves
as a receptor for apoE containing low density lipopro-model, the heparin chain extends from Arg-205 and
-206, taking a route past one or more N-terminal resi- tein, promoting its uptake in lipid metabolism [30]. As
Figure 6. Schematic Depicting the Proposed Heparan Sulfate Mediated Assembly of Annexin V on the Cell Membrane Surface
(a) Annexin V is bound to heparan sulfate at all three subsites (1 at Arg-205, 2 at Arg-287, and 3 at Arg-23) and delivered to the cell surface.
(b) Subsite 3 releases the heparan sulfate chain as annexin preferentially interacts with the membrane phospholipids. Additional molecules
of annexin V assemble laterally to form a multimeric anti-thrombotic shield on the cell surface (not shown).
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resulting in thrombin inhibition and anticoagulation [36].Table 4. Crystallographic Statistics
The anticoagulant properties of annexin V are inextrica-
Data Collection
bly tied to its ability to preferentially bind acidic phos-Space group R3
pholipids, particularly phosphatidylserine, on cell mem-Unit cell dimensions (A˚) a 5 155.87, c 5 37.34
brane surfaces. Exposure of PS on the outer membranesResolution range (A˚) 100–1.9
Measured reflections 144,885 of activated cells is a physiological signal for the onset
Unique reflections 26,655 of processes such as coagulation and apoptosis. Extra-
Completeness (%) overall (final shell)1 92.1 (93.5) cellular annexin V recognizes this signal, binds to PS
,I/sI. (final shell)1 16.5 (10.5)
components of the membrane, and self-assembles lat-Rmerge (%) (final shell)1,2 8.6 (21.9)
erally into an organized array. This annexin array formsRefinement
a shield that prevents excessive clot formation.Resolution (A˚) 100–1.9
Rcryst3 0.205 The current data and structure-based model of
Rfree4 0.236 annexin V behavior at the cell surface suggest that GAG
No. non-H atoms interactions may facilitate the role of the annexin as an
protein (1 mol/AU) 2,504
anti-thrombotic shield. Membrane-bound annexin V hastetrasaccharides 140
a highly-ordered structure in which trimers and higherwaters 284
oligomers form an extended 2-D crystalline array [1, 37].ions 9
Average B (A˚2) Electron microscopic data show that a layer of annexin
main chain 20.7 V coats the membrane surface with the thickness of a
side chain 22.9 single annexin molecule, consistent with lateral self-
tetrasaccharides 47.8
assembly [10, 37]. While the convex annexin V surfacewaters 28.8
adheres to the membrane surface, heparan sulfate rec-ions 29.7
ognition and binding can place at the concave annexinRmsd5
bonds (A˚) 0.0046 surface. This surface has high-affinity binding sites for
angles (8) 1.09 heparin but not for membrane phospholipids. The dual
binding mode would permit membrane-bound annexin1 Values taken from output of SCALEPACK [41].
2 Rmerge 5 SjI1 2 ,I.j/SII 3 100 where II is the intensity of an individual to present an extensive binding surface for proteoglycan
reflection and ,I. is the mean intensity of that reflection. heparan sulfate chains. Depending upon the order of
3 Rcryst 5 SjjFpj 2 jFcalcjj/SjFpj 3 100 where jFcalcj is the calculated binding, the GAG chains may increase the stability of
structure factor.
the membrane-bound annexin layer and/or may assist4 Rfree is as defined by Bru¨nger [43].
in the presentation of correctly oriented annexin mole-5 rmsd 5 root-mean-square deviation.
cules to the membrane surface. Because extracellular
annexin V membrane binding specifically occurs at en-
dothelial cell membranes that have been activated by
in the case of annexin V, apoE contains multiple heparin phosphatidylserine exposure [38], as occurs at the onset
binding sites that occur both outside and within its mem- of blood coagulation, proteoglycan GAG chains might
brane binding domain [31]. The crystal structure of the usefully sequester free annexin in readiness for activa-
annexin-heparin tetrasaccharide complex is also the tion. GAG binding also may assist in docking other hepa-
first to describe a heparin oligosaccharide binding to rin binding proteins to the membrane-bound annexin
a protein in which calcium ions are essential for the layer, thus localizing them to the cell surface. Such a
interaction. Although there are currently over 100 exam- mechanism could underlie the roles attributed to annexin
ples of proteins that bind heparin [16, 27], few of these V and annexin II as receptors for binding viruses [39]
interactions are calcium-dependent. Other than certain and plasminogen/tissue plasminogen activator [5], re-
annexins, the only known examples of calcium-depen- spectively.
dent heparin binding include serum amyloid P compo-
nent (SAP) [32] and P and L-selectins [33]. In these Experimental Procedures
examples, it has never been ascertained whether the
Protein Expression and Purificationcation is involved directly, e.g., bridging heparin and
Recombinant rat annexin V proteins were prepared as describedprotein through shared calcium coordination, or indi-
previously [18]. Site-directed mutagenesis was performed using the
rectly, e.g., by altering the conformation of the protein. Clontech transformer kit. The following changes in codons were
The present work clearly supports the latter mode of made to produce the R23E, R205A and R287A mutants, respectively:
CGG!GAG, AGA!GCA, AGG!GCA. Each mutation was verifiedinteraction.
by double-strand DNA analysis. Proteins were expressed from cul-
tures of Escherichia coli strain JM101 and purified using lipid affinityBiological Implications
chromatography [18]. The identity of the N terminus was confirmed
by N-terminal sequence analysis of the first four residues and by
Heparin and heparan sulfate are known to promote pro- mass spectrometry.
tein assembly. For example, heparan sulfate proteogly-
Heparin Tetrasaccharide Isolationcan is believed to assemble two molecules of fibroblast
A tetrasaccharide fragment from heparin was prepared by partialgrowth factor (FGF) and FGF-receptor to form a penta-
digestion of porcine intestinal mucosal heparin with heparin lyasemeric complex responsible for signal transduction [34,
I and purified to homogeneity by preparative strong anion exchange
35]. Heparin binding is an important component in pro- (SAX) high performance liquid chromatography [40]. As a result of
cesses related to blood coagulation. Thrombin and anti- this procedure, the heparin fragment contains an unsaturated uronic
acid moiety at its non-reducing end and a mixture of a and b anomersthrombin III form a ternary complex on a heparin chain
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